March 14 (Reuters) - Pfizer Inc agreed to extend its COVID-19 vaccine contract from 2023 to 2026 with the European Union and offered to cut the number of doses being supplied, the Financial Times reported on Tuesday, citing people with knowledge of the matter. (Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel)
Market Closed -
Other stock markets
|
After market 00:58:13 | |||
28.16 USD | +1.26% | 28.25 | +0.32% |
05-06 | Pfizer: Citi analyst appointed Chief Strategy Officer | CF |
05-06 | Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.19% | 157B | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer agrees to revise EU COVID vaccine contract - FT